Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
Abstract Introduction Diabetic ketoacidosis (DKA) is associated with inflammation and increased lipolysis. The macrophage activation marker, soluble CD163 (sCD163), is associated with obesity, non‐alcoholic fatty liver disease and type 2 diabetes. We aimed to investigate whether sCD163 correlates wi...
Main Authors: | Mads Svart, Nikolaj Rittig, Niels Møller, Holger J Møller, Henning Gronbaek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.12869 |
Similar Items
-
Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
by: Nikolaj Rittig, et al.
Published: (2018-01-01) -
Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
by: Ermina Bach, et al.
Published: (2019-02-01) -
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
by: Rasmus Hvidbjerg Gantzel, et al.
Published: (2021-01-01) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
by: Marlene Christina Nielsen, et al.
Published: (2020-05-01) -
Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis
by: Mohamed Yousri Taher, et al.
Published: (2021-07-01)